Gianpaolo Reboldi

Professor of Nephrology

Università degli Studi di Napoli Federico II

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gianpaolo Reboldi is a Professor of Nephrology at Università degli Studi di Perugia, Italy. His research interests focus on the cardiovascular implications of hypertension, intensive blood pressure targeting, and the management of diabetic kidney disease. Recent publications highlight the impact of blood pressure control on cardiovascular outcomes, the relationship between metabolic health and cardiovascular risk, and novel therapeutic approaches in nephrology.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (12)

Alessandro Mengozzi

Assistant Professor

University of Pisa

ITALY

View details

Francesca Viazzi

University of Genova

ITALY

View details

ROSARIO CIANCI

Professore Associato di Nefrologia

Sapienza University of Rome

ITALY

View details

Paolo Palatini

University of Padova

ITALY

View details

Maria Lorenza Muiesan

University of Brescia

ITALY

View details

Gianfranco Parati

Senior Professor of Cardiovascular Medicine, past Director of the School of Specialization in Cardiovascular Diseases

University of Milano-Bicocca

ITALY

View details

Simon Davies

Professor of Nephrology and Dialysis Medicine

Keele University

UNITED KINGDOM

View details

Massimo Cirillo

Professore ordinario di Nefrologia

Università degli Studi di Napoli Federico II

ITALY

View details

Olof Heimbürger

Karolinska University Hospital

SWEDEN

View details

Stefano Masi

Associate Professor

University of Pisa

ITALY

View details

Massimo Salvetti

Professor

University of Brescia

ITALY

View details

PIETRO Cirillo

University of Bari Aldo Moro

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gianpaolo Reboldi

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Baseline risk and outcome benefit from intensive blood pressure targeting. A systematic review

Benefits of intensive blood pressure control on cardiovascular mortality: ESPRIT and BPROAD change the scene

Hemodialysis Timing Influences Sleep Profile

Risk of Cardiovascular Events in Metabolically Healthy Overweight or Obese Adults: Role of LDL-Cholesterol in the Stratification of Risk

Serum Uric Acid, Hypertriglyceridemia, and Carotid Plaques: A Sub-Analysis of the URic Acid Right for Heart Health (URRAH) Study

Rationale and design of ELIXIR, a randomized, controlled trial to evaluate efficacy and safety of XyloCore, a glucose-sparing solution for peritoneal dialysis

Prognostic impact of hypertension grading

The lowest well tolerated blood pressure: A personalized target for all?

Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection

Managing hyperkalemia in patients with heart failure on guideline-directed medical therapy: challenges and opportunities

Interpretation of Ambulatory Blood Pressure Monitoring for Risk Stratification in Hypertensive Patients: The ‘Ambulatory Does Prediction Valid (ADPV)’ Approach

Chyloperitoneum in Peritoneal Dialysis Secondary to Calcium Channel Blocker Use: Case Series and Literature Review

How Low Should We Go With Home Blood Pressure in Elderly Patients With Atrial Fibrillation?

COVID-19, vaccines and deficiency of ACE2 and other angiotensinases. Closing the loop on the "Spike effect"

Benefits of more intensive versus less intensive blood pressure control. Updated trial sequential analysis

Blood Pressure Increase following COVID-19 Vaccination: A Systematic Overview and Meta-Analysis

Chronic Kidney Disease and Left Ventricular Hypertrophy. Potent Modifiers of the Prognostic Impact of Circadian Blood Pressure Changes

Tight Blood Pressure Control in Chronic Kidney Disease

Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later

Collaborators (12)

Alessandro Mengozzi

Francesca Viazzi

ROSARIO CIANCI

Paolo Palatini

Maria Lorenza Muiesan

Gianfranco Parati

Simon Davies

Massimo Cirillo

Olof Heimbürger

Stefano Masi

Massimo Salvetti

PIETRO Cirillo

Make your next move.